Back to
Royal Bank of Canada
AUPH
Showing 8 of 28 quarters
Position history for
Royal Bank of Canada's holdings in Aurinia Pharmaceuticals Inc
Yes. Royal Bank of Canada holds 16,135 shares of AUPH (Aurinia Pharmaceuticals), worth $273,000, as of its Q2 2026 13F filing. It increased the position by 5,158 shares (+47.0%) from Q1 2026. Royal Bank of Canada has held AUPH in every 13F on record since Q3 2019, 28 quarterly filings.
Current Value
$273,000
Current Shares
16,135
Total Value Change
-$138,000
Total Shares Change
-39,972
Quarter-by-Quarter History